Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation

The cryopreservation of ovarian tissue with subsequent transplantation of the tissue represents an established method of fertility protection for female patients who have to undergo gonadotoxic therapy. The procedure can be performed at any point in the cycle and thus generally does not lead to any delay in oncological therapy. With the aid of this procedure, more than 130 births to date worldwide have been able to be recorded. The birth rate is currently approximately 30% and it can be assumed that this will increase through the further optimisation of the cryopreservation and surgical technique. The concept paper presented here is intended to provide guidance for managing cryopreservation and transplantation of ovarian tissue to German-speaking reproductive medicine centres.

[1]  M. Lux,et al.  Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) – Recommendations and Statements for Girls and Women , 2018, Geburtshilfe und Frauenheilkunde.

[2]  E. Ernst,et al.  Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort , 2018, Journal of Assisted Reproduction and Genetics.

[3]  M. Beckmann,et al.  Fertility protection: complications of surgery and results of removal and transplantation of ovarian tissue. , 2017, Reproductive biomedicine online.

[4]  M. von Wolff,et al.  Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques , 2017, Archives of Gynecology and Obstetrics.

[5]  T. Fehm,et al.  Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation , 2017, Archives of Gynecology and Obstetrics.

[6]  J. Kjer,et al.  The influence of unilateral oophorectomy on the age of menopause , 2017, Climacteric : the journal of the International Menopause Society.

[7]  F. Martínez Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. , 2017, Fertility and sterility.

[8]  Shangwei Li,et al.  Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and meta-anlaysis , 2017, Scientific Reports.

[9]  K. Oktay,et al.  Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis , 2017, Reproductive Sciences.

[10]  A. Guilmain,et al.  Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases , 2017, Human reproduction.

[11]  E. Gastal,et al.  Ovarian fragment sizes affect viability and morphology of preantral follicles during storage at 4°C. , 2017, Reproduction.

[12]  L. Wildt,et al.  What is new in 2017? Update on fertility preservation in cancer patients. , 2017, Minerva endocrinologica.

[13]  K. Heusinger,et al.  Operative techniques and complications of extraction and transplantation of ovarian tissue: the Erlangen experience , 2017, Archives of Gynecology and Obstetrics.

[14]  K. Sørensen,et al.  Cryopreservation of ovarian tissue for fertility preservation in a large cohort of young girls: focus on pubertal development , 2016, Human reproduction.

[15]  M. Montag,et al.  Chapter 15 Development of a Nationwide Network for Ovarian Tissue Cryopreservation. , 2017, Methods in molecular biology.

[16]  P. Humaidan,et al.  86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children , 2017, Journal of Assisted Reproduction and Genetics.

[17]  J. Hendriks,et al.  Clinically applied procedures for human ovarian tissue cryopreservation result in different levels of efficacy and efficiency , 2016, Journal of Assisted Reproduction and Genetics.

[18]  M. Beckmann,et al.  Surgical Aspects of Ovarian Tissue Removal and Ovarian Tissue Transplantation for Fertility Preservation , 2016, Geburtshilfe und Frauenheilkunde.

[19]  M. Hohl,et al.  Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. , 2016, Human reproduction.

[20]  A. Thurin-Kjellberg,et al.  Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries – compilation of 20 years of multicenter experience , 2016, Acta obstetricia et gynecologica Scandinavica.

[21]  M. Beckmann,et al.  Ovarian tissue cryopreservation and retransplantation--what do patients think about it? , 2016, Reproductive biomedicine online.

[22]  M. von Wolff,et al.  Transplantation of ovarian tissue to postpone menopause - is it really more advantageous for women's health than menopause hormone therapy? , 2015, Reproductive biomedicine online.

[23]  C. Andersen,et al.  Optimizing outcomes from ovarian tissue cryopreservation and transplantation; activation versus preservation. , 2015, Human reproduction.

[24]  T. Bruckner,et al.  Fertility-preservation counselling and treatment for medical reasons: data from a multinational network of over 5000 women. , 2015, Reproductive biomedicine online.

[25]  A. Ferster,et al.  Live birth after autograft of ovarian tissue cryopreserved during childhood. , 2015, Human reproduction.

[26]  Jacques Donnez,et al.  Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice , 2015, Journal of Assisted Reproduction and Genetics.

[27]  J. Donnez,et al.  Ovarian tissue freezing: current status , 2015, Current opinion in obstetrics & gynecology.

[28]  M. Beckmann,et al.  Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. , 2015, Fertility and Sterility.

[29]  J. Donnez,et al.  Transplantation of ovarian tissue. , 2014, Best practice & research. Clinical obstetrics & gynaecology.

[30]  W. Wallace,et al.  Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation , 2014, The Lancet. Oncology.

[31]  G. Griesinger,et al.  Effects of supra-zero storage on human ovarian cortex prior to vitrification-warming. , 2014, Reproductive biomedicine online.

[32]  M. Montag,et al.  Efficacy of ovarian tissue cryopreservation in a major European center , 2014, Journal of Assisted Reproduction and Genetics.

[33]  Ovarian tissue cryopreservation: a committee opinion. , 2014, Fertility and sterility.

[34]  P. Hindmarsh,et al.  Induction of puberty by autograft of cryopreserved ovarian tissue in a patient previously treated for Ewing sarcoma. , 2013, European journal of cancer.

[35]  Claus Yding Andersen,et al.  Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. , 2013, Fertility and sterility.

[36]  J. Donnez,et al.  A review of 15 years of ovarian tissue bank activities , 2013, Journal of Assisted Reproduction and Genetics.

[37]  N. Garrido,et al.  Accumulation of oocytes: a new strategy for managing low-responder patients. , 2012, Reproductive biomedicine online.

[38]  C. Poirot,et al.  Induction of puberty by autograft of cryopreserved ovarian tissue , 2012, The Lancet.

[39]  M. Beckmann,et al.  Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. , 2012, Fertility and sterility.

[40]  M. Beckmann,et al.  Retransplantation of cryopreserved ovarian tissue: the first live birth in Germany. , 2012, Deutsches Arzteblatt international.

[41]  Michael W. Anderson,et al.  Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. , 2011, Fertility and sterility.

[42]  M. Montag,et al.  Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT , 2011, Archives of Gynecology and Obstetrics.

[43]  P. Oppelt,et al.  First retransplantation of cryopreserved ovarian tissue following cancer therapy in Germany. , 2008, Deutsches Arzteblatt international.

[44]  W. Wallace,et al.  Predicting age of ovarian failure after radiation to a field that includes the ovaries. , 2005, International journal of radiation oncology, biology, physics.

[45]  J. Donnez,et al.  Livebirth after orthotopic transplantation of cryopreserved ovarian tissue , 2004, The Lancet.

[46]  A. Nyboe Andersen,et al.  Survival of primordial follicles following prolonged transportation of ovarian tissue prior to cryopreservation. , 2003, Human reproduction.

[47]  R. Gosden,et al.  Low temperature storage and grafting of human ovarian tissue , 2000, Molecular and Cellular Endocrinology.

[48]  R. Gosden,et al.  Ovary and ovulation: Low temperature storage and grafting of human ovarian tissue , 1996 .

[49]  R. Webb,et al.  Restoration of fertility to oophorectomized sheep by ovarian autografts stored at-196°C , 1994 .

[50]  D. Baird,et al.  Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. , 1994, Human reproduction.